Strategic objectives

• Synthesize a platform of dendritic systems with the capacity to act as non-viral vectors and in the transport of drugs and nucleic acids.
• Synthesize a platform of dendritic systems with a therapeutic activity against cancer, microbial diseases or as antiviral agents.
• Establish collaborations with groups within the Institute with common research interests.
• Participate in European project applications, for which the Institute is eligible to partipate.

Research lines

• Synthesis of carbosilane dendritic systems for application as non-viral vectors of drugs or nucleic acids, or as therapeutic agents.
• Dendronization of molecules of pharmacological interest (drugs, peptides, antibodies, etc.)
• Preparation of carbosilane metal dendritic systems aimed at bio-inorganic applications.
• Dendronization of nanostructured materials for application in biomedicine.
• Application of dendritic systems against microbial resistance.
• Application of dendritic systems against viruses, particularly HIV.
• Applications of dendritic systems against cancer.
• Applications of dendritic systems against neurodegenerative diseases.